Synthetic Biology and the “Bioeconomy”: Feeding Fuel to the Fire of Landgrabs and
Biodiversity Loss
By Eric Hoffman and Jeff Conant,
Global Forest Coalition
| 02. 14. 2013
[For footnotes, see here]
The industrial revolution replaced wood for fossil fuels as the driver of the engine of progress, leaving living plants to take a back seat in energy production. Now, with the advent of a set of technologies known as synthetic biology, industry groups and the US Department of Energy are celebrating the advent of a new “bioeconomy” – an energy and materials economy in which products and processes previously derived from petroleum will be produced through the exploitation of biomass and biotechnology. By employing the rapidly expanding techniques of synthetic biology, the new industrialists want to turn microbes into “living chemical factories” engineered to produce substances they would not produce naturally, such as biofuels, bio-plastics, industrial chemicals and oils, and even medicines.
However, early indications show that such an approach likely harbors all of the ill-effects of the fossil fuel economy – simply swapping out black carbon for green – combined with the assault on biodiversity brought on by biotechnologies such as genetic engineering of crops. Humans have already caused a state-shift in the global ecosystem...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...